Sinopharm Group Co's total assets for Q4 2023 were ¥383.39B, a decrease of -8.21% from the previous quarter. HK:1099 total liabilities were ¥263.08B for the fiscal quarter, a -13.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.